|
Baseline
|
6 h
|
One week
|
---|
LVEF | | | |
Group 1 | 0.48 ± 0.06 | 0.39 ± 0.06a | 0.46 ± 0.05 |
Group 2 | 0.47 ± 0.04 | 0.44 ± 0.04 | 0.48 ± 0.03 |
LVEDV (mL) | | | |
Group 1 | 40.4 ± 3.1 | 40.8 ± 3.0 | 48.5 ± 4.0a |
Group 2 | 38.0 ± 4.7 | 39.0 ± 6.6 | 37.4 ± 5.4 |
LVESV (mL) | | | |
Group 1 | 21.0 ± 1.9 | 24.7 ± 1.8 | 26.2 ± 3.2a |
Group 2 | 20.2 ± 2.4 | 21.8 ± 3.4 | 19.4 ± 2.3 |
- Group 1: coronary microembolization with 120,000 microspheres.
- Group 2: coronary microembolization with 120,000 microspheres and pretreatment with methylprednisolone.
- LVEF: left ventricular ejection fraction; LVEDV: left ventricular end dilatolic volume; LVESV: left ventricular systolic volume.
- aCompared with baseline P <0.01.